CCK2 receptor as a therapeutic target for neuroendocrine tumours

被引：0
|
作者：
Stubbs, M [1 ]
Khan, K [1 ]
Savage, K [1 ]
McStay, M [1 ]
Dhillon, AP [1 ]
Caplin, ME [1 ]
机构：
[1] UCL Royal Free & Univ Coll Med Sch, London NW3 2PF, England
来源：
GUT | 2003年 / 52卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
108
引用
收藏
页码：A29 / A30
页数：2
相关论文
共 50 条
  • [1] CCK2 receptor as a therapeutic target for neuroendocrine tumours
    Stubbs, M
    Khan, K
    Savage, K
    McStay, M
    Dhillon, AP
    Caplin, ME
    ENDOCRINE-RELATED CANCER, 2003, 10 (04) : 505 - 505
  • [2] Gastrin and CCK2 processing in neuroendocrine tumours and cell lines: Therapeutic targets
    Khan, K
    Stubbs, M
    Shah, T
    Savage, K
    Dhillon, AP
    Caplin, ME
    GUT, 2006, 55 : A9 - A10
  • [3] CCK2 receptor antagonists
    McDonald, IM
    EXPERT OPINION ON THERAPEUTIC PATENTS, 2001, 11 (03) : 445 - 462
  • [4] Netazepide, a Gastrin/CCK2 Receptor Antagonist, Can Eradicate Gastric Neuroendocrine Tumours in Patients with Autoimmune Chronic Atrophic Gastritis
    Boyce, M.
    Moore, A. R.
    Parsons, B. N.
    Lloyd, K. A.
    Sagatun, L.
    Thomsen, L.
    Varro, A.
    Fossmark, R.
    Waldum, H. L.
    Pritchard, D. M.
    NEUROENDOCRINOLOGY, 2016, 103 : 78 - 78
  • [5] Netazepide, a Gastrin/CCK2 Receptor Antagonist, Can Eradicate Gastric Neuroendocrine Tumours in PatientsWith Autoimmune Chronic Atrophic Gastritis
    Boyce, Malcolm
    Moore, Andrew R.
    Parsons, Bryony
    Lloyd, Katie
    Sagatun, Liv
    Varro, Andrea
    Fossmark, Reidar
    Waldum, Helge
    Pritchard, D. Mark
    PANCREAS, 2019, 48 (03) : 429 - 429
  • [6] CCK2 gastrin receptor as a potential target for therapy in leukaemia cell lines
    Stubbs, M
    Khan, K
    Wickremasinghe, RG
    Ganeshaguru, K
    Caplin, ME
    ONCOLOGY REPORTS, 2005, 14 (04) : 1055 - 1058
  • [7] Vectorization of magnetic nanoparticles for the diagnosis and treatment of neuroendocrine tumors that overexpress the CCK2 receptor
    Sanchez, C.
    Clerc, P.
    Gigoux, V
    Escrieut, C.
    Fourmy, D.
    BULLETIN DU CANCER, 2011, 98 : S64 - S65
  • [8] Process development of the CCK2 receptor ligand
    Anzalone, Luigi
    Abdel-Magid, Ahmed F.
    Cohen, Judith
    Mehrman, Steven
    Villani, Frank J., Jr.
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2007, 233
  • [9] CCK2 receptor splice variant with intron 4 retention in human gastrointestinal and lung tumours
    Koerner, Meike
    Waser, Beatrice
    Reubi, Jean Claude
    Miller, Laurence J.
    JOURNAL OF CELLULAR AND MOLECULAR MEDICINE, 2010, 14 (04) : 933 - 943
  • [10] TARGETING OF CCK2 RECEPTOR EXPRESSING TUMOURS USING AN 111IN-LABELLED MINIGASTRIN DIMER
    Sosabowski, J.
    Matzow, T.
    Foster, J.
    Mather, S.
    JOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS, 2009, 52 : S327 - S327
12345